News
A new study shows that tiny gold particles could circumvent damaged photoreceptors in patients with macular degeneration and ...
2d
Daily Express US on MSNNew treatment offers hope to those who have lost their sight due to retina diseaseImagine a world where lost vision could be restored. A new groundbreaking study might just turn this dream into reality, ...
3d
Futurism on MSNDoctors Say Injecting Gold Into Eyeballs Could Restore Lost VisionGold particles could help reproduce the visual signals of damaged photoreceptor cells and restore vision, according to new ...
What Is Diabetic Macular Edema (DME ... may refer you to an ophthalmologist who specializes in the retina and can provide treatment. If you catch it early, there's a chance you can stop long ...
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept injection 8mg for the treatment of macular edema following ...
Scientists enhance eye imaging with AI, achieving high-resolution views of retinal cells, potentially revolutionizing disease ...
Age-related macular degeneration (AMD), the leading cause of adult blindness, affects nearly half of Oklahomans over age 80.
8d
News-Medical.Net on MSNNew research aims to illuminate the causes of age-related macular degenerationAge-related macular degeneration begins with weakening of retinal pigment epithelium cells (RPEs), a layer of cells that support the retina's photoreceptors. When degeneration occurs, the affected ...
News Medical on MSN12d
Gold Nanoparticles Restore Vision in Macular DegenerationA new study shows that gold nanoparticles injected into the retina can restore vision in mice with retinal degeneration, offering a less invasive alternative to current retinal prostheses.
FDA Grants Priority Review to Regeneron’s Eylea for Macular Edema Following Retinal Vein Occlusion
Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks ...
The FDA told Regeneron in a complete response letter that while it didn't identify any issues with the safety or efficacy of the drug in its approved indications and dosing regimens, the agency didn't ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results